Suppr超能文献

鉴定来自反枝苋花粉的一种新过敏原,Ama r 2。

Identification of a new allergen from Amaranthus retroflexus pollen, Ama r 2.

机构信息

Immunology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Iran.

出版信息

Allergol Int. 2011 Sep;60(3):309-16. doi: 10.2332/allergolint.10-OA-0279. Epub 2011 Mar 25.

Abstract

BACKGROUND

Pollinosis from Amaranthus retroflexus pollen is a common cause of respiratory allergy in Iran with a high positive rate (68.8%) among Iranian allergic patients. The aim of the present study was to evaluate the allergenicity of the A. retroflexus pollen profilin.

METHODS

Using sera from twelve patients allergic to A. retroflexus pollen, IgE-binding proteins from the A. retroflexus pollen extract was identified by immunoblotting. The cDNA of A. retroflexus pollen profilin was amplified, then cloned into the pET-21b (+) vector, expressed in Escherichia coli, and finally purified by metal affinity chromatography. The IgE-binding capacity of the recombinant protein was then analyzed by the ELISA, immunoblotting, and inhibition assays, as well as by the skin prick test (SPT).

RESULTS

Immunoblotting results indicated a 14.6kDa protein with IgE-reactivity to 33% (4/12) among A. retroflexus pollen-allergic patients. Nucleotide sequencing of the cDNA revealed an open reading frame of 399 bp encoding for 133 amino acid residues which was belonged to the profilin family and designated as Ama r 2. A recombinant Ama r 2 (rAma r 2) was then produced in E. coli as a soluble protein which showed a strong IgE-reactivity via ELISA confirmed by the SPT. Inhibition experiments revealed high IgE cross-reactivities with the profilins from other plants.

CONCLUSIONS

The profilin from the A. retroflexus pollen, Ama r 2, was firstly identified as an allergen. Moreover, rAma r 2 was produced in E. coli as a soluble immunoreactive protein with an IgE-reactivity similar to that of its natural counterpart.

摘要

背景

反枝苋花粉引起的花粉症是伊朗常见的呼吸道过敏原因之一,在伊朗过敏患者中阳性率高达 68.8%。本研究旨在评估反枝苋花粉丝氨酸蛋白酶抑制剂的变应原性。

方法

采用十二例反枝苋花粉过敏患者的血清,通过免疫印迹法鉴定反枝苋花粉提取物中的 IgE 结合蛋白。扩增反枝苋花粉丝氨酸蛋白酶抑制剂 cDNA,克隆到 pET-21b(+)载体中,在大肠杆菌中表达,然后通过金属亲和层析纯化。通过 ELISA、免疫印迹和抑制试验以及皮肤点刺试验(SPT)分析重组蛋白的 IgE 结合能力。

结果

免疫印迹结果显示,33%(4/12)的反枝苋花粉过敏患者血清中存在 14.6kDa 的 IgE 反应性蛋白。cDNA 测序揭示了一个 399bp 的开放阅读框,编码 133 个氨基酸残基,属于丝氨酸蛋白酶抑制剂家族,命名为 Ama r 2。在大肠杆菌中成功表达了可溶的重组 Ama r 2(rAma r 2),并通过 SPT 确认 ELISA 结果显示具有较强的 IgE 反应性。抑制实验表明,与其他植物的丝氨酸蛋白酶抑制剂具有较高的 IgE 交叉反应性。

结论

反枝苋花粉丝氨酸蛋白酶抑制剂,Ama r 2,首次被鉴定为过敏原。此外,rAma r 2 在大肠杆菌中作为一种可溶的免疫反应性蛋白表达,其 IgE 反应性与天然蛋白相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验